PDZD4 and neoplasm: With the two new MG analogs with different modifications within the N-terminal peptide sequence, a tumor uptake of 22.2 ± 6.2% IA/g was observed for [177Lu]Lu-1 and of 32.1 ± 4.1% IA/g for [177Lu]Lu-2.